cell schock - (Feb/09/2010 )
Normally, DNA molecules are too large to enter in the cell by themselves; it's a natural cellular defense to keep unwanted objects from entering.
But with the cell doors artificially stimulated, more of the genetic material in the vaccine is able to make it to a cell's replication center, increasing the number of antibodies the cell is able to produce.
This cell-shock technology is able to increase the uptake of DNA without the side effects normally associated with traditional vaccine types.
In other words, cell-shock technology is unmatched in its ability to safely, effectively, and economically deliver a genetically tailored vaccine to disease-ridden cells.
Normally, DNA molecules are too large to enter in the cell by themselves; it's a natural cellular defense to keep unwanted objects from entering.
But with the cell doors artificially stimulated, more of the genetic material in the vaccine is able to make it to a cell's replication center, increasing the number of antibodies the cell is able to produce.
This cell-shock technology is able to increase the uptake of DNA without the side effects normally associated with traditional vaccine types.
In other words, cell-shock technology is unmatched in its ability to safely, effectively, and economically deliver a genetically tailored vaccine to disease-ridden cells.
-eeasy-
eeasy, would you disclose the name of the company who invented cell shock technology?
-violini-
violini on Feb 10 2010, 11:29 AM said:
eeasy, would you disclose the name of the company who invented cell shock technology?
Inovio Biomedical.
-violini-